五洲医疗收盘上涨19.99%，滚动市盈率73.48倍，总市值26.25亿元

Core Insights - Wuzhou Medical's stock closed at 38.6 yuan, up 19.99%, with a rolling PE ratio of 73.48, marking a new low in 420 days, and a total market capitalization of 2.625 billion yuan [1] - The average PE ratio in the medical device industry is 51.42, with a median of 37.44, placing Wuzhou Medical at the 98th position in the industry ranking [1] - As of the first quarter of 2025, three institutions hold shares in Wuzhou Medical, with a total of 293,800 shares valued at 0.08 million yuan [1] Company Overview - Wuzhou Medical specializes in the research, manufacturing, and sales of disposable sterile infusion medical devices, along with other diagnostic and nursing supplies [1] - Key products include syringes, safety syringes, insulin syringes, infusion sets, blood transfusion sets, and various types of needles [1] Financial Performance - For the first quarter of 2025, Wuzhou Medical reported revenue of 104 million yuan, a year-on-year increase of 15.59%, while net profit was 5.6345 million yuan, reflecting a year-on-year decrease of 43.00% [1] - The sales gross margin for the company stood at 14.62% [1]